SANA

Conviction 7HealthcareScan · Thu, Sep 24, 2026

Sana Biotechnology, Inc. (SANA) closed at $2.96 (-3.90%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 38, RS Rating 38, -50.0% from its 52-week high, -29.4% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

SANA$2.96-3.90%

ResistanceSupportVol 14

Vol MA14 4.7M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Sana Biotechnology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.sana.com ↗

Price2.96

Change-3.90%

Gap-0.49%

Rel volume1.36×

Avg volume3.92M

Avg $ vol12.81M

SMA 203.41

SMA 503.46

SMA 2003.65

Price vs 50-14.42%

Price vs 200-18.82%

MA stackbearish

50/200 cross—

Supertrenddown · 3.66

RSI (14)38

MACD hist-0.04

MACD cross—

Stoch %K / %D9 / 22

ADX (14)23

+DI / −DI19 / 29

RSI divergence—

MACD divergence—

ATR %7.74%

ADR %6.30%

52w high5.92

52w low2.68

From 52w high-50.00%

Above 52w low+10.45%

New 52w highNo

SqueezeOff

Bollinger width45.43%

%B0.21

Donchian pos7.04%

Donchian high4.22

Donchian low2.87

AVWAP (52w high)3.92

vs AVWAP high-24.40%

AVWAP (52w low)3.37

vs AVWAP low-12.24%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d1.36×

Avg vol (14d)4.7M

Avg vol (20d)3.92M

Avg $ vol (20d)12.81M

Market cap886.11M

RS Rating38 / 99

RS 3m (vs SPY)-13.69%

RS 6m (vs SPY)-21.33%

RS line new highNo

Trend template0/8

Technical rank20.6

1 week-4.52%

1 month-27.80%

3 months-9.20%

6 months-4.52%

1 year-9.20%

YTD-29.36%

P/E-3.63

P/B5.73

P/S—

P/FCF-6.12

EPS-0.9600

Div yield—

ROE-157.97%

ROA-56.58%

Debt/Eq—

Current1.38

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth8.47%

Price target8.00

Target upside170.27%

Analyst ratingBuy

Institutional64.42%

Ent. value829.03M

Revenue—

Net income-63.63M

Gross profit—

Free cash flow-144.77M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out278.29M

Employees142

ListedThu, Feb 4, 2021

Free float157.95M

Float %58.5%

Short interest41.56M

Days to cover16.1d

Short volume65.8%

Squeeze score88 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.13 vs −$0.15

Last surprise+13.3% beat

Setup gradeD

Conviction7 / 100

Pattern quality—

Tech rank20.6 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.17

Support2.93

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 30
1 scan
→
Breaking out now
Aug 3
1 scan

Congress activity

Disclosed STOCK Act trades in SANA

All disclosures →

No recent disclosed trades by Congress in SANA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SANA

Insider	Side	Shares	Value	Traded	Filed
PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer · Common Stock · 2026-08-27	Tax	41.16K	$169K	2026-08-27	2026-08-27
PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer · Restricted Stock Units · 2026-08-26	Exercise	125K	—	2026-08-26	2026-08-27
PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer · Common Stock · 2026-08-26	Exercise	125K	—	2026-08-26	2026-08-27
Bishop Hans Edgar Director · Common Stock · 2026-07-06	Grant	6.3K	—	2026-07-06	2026-07-07
Mulligan Richard Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05
Bishop Hans Edgar Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05
NELSEN ROBERT Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05
Seitz Michelle Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05
Yang Patrick Y Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05
REICIN ALISE Director · Stock Option (Right to Buy) · 2026-06-04	Grant	90K	$0	2026-06-04	2026-06-05

SEC filings

EDGAR filings in SANA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.